Main navigation

LATEST NEWS!

Congratulations Zahra and Jonathan!

Zahra was recently winner for the "Featured Research Award" for her abstract submitted to the Canadian Cardiovascular Congress (CCC), Ottawa, Ontario. Oct 27-30, 2022.

Azizi Z, Lindner S, Shiba Y, Raparelli V, Norris CM, Kublickiene K, Herrero MT, Kautzky-Willer A, Klimek P, El EmamK, Pilote L and the GOING-FWD Investigators. A Comparison of Synthetic Data Generation and Federated Analysis for Performing an International Assessment of Gender Effects on Cardiovascular Health. Canadian Cardiovascular Congress (CCC), Ottawa, Ontario (Hybrid). Oct 27-30, 2022.

Jonathan has been selected as best research presentation award at the CSIM annual meeting on October 12-15, 2002 in Victoria BC.

Houle J, Proietti M, Raparelli V, Azizi Z, Atzema CL, Norris C, Abrahamowicz M, Lip GHY, Boriani G, Pilote L, on behalf of ESC-EHRA EORP-AF General Long-Term Investigators. Gendered Social Determinants of Health and Risk of Major Adverse Outcomes in Atrial Fibrillation: An Analysis from the ESC-EHRA EURObservational Research Programme in Atrial Fibrillation General Long-Term Registry. CSIM Annual Meeting 2022, October 12-15, 2022, Victoria, BC. *3rd place best research presentation award.“

About

What is GOING-FWD?

Project title: Gender Outcomes INternational Group: to Further Well-being Development (GOING-FWD)

Learn more

Educational activities

Sex and gender dimensions in education and training will include face-to-face and online modules, tools and workshops designed to improve health outcomes across non-communicable diseases.

Learn more

We also aim to construct innovative ways to disseminate the application of gender measurement towards personalized approaches to chronic disease prevention, diagnosis and treatment.

Our research focuses on the following:

1. Gender-related variables.

2. Cost-sensitive and patient-reported outcome measures.

3. Knowledge translation and dissemination

Learn More

Workshops, Conferences and Lectures.

Learn More

Home

Going forward Consortium integrates sex and gender dimensions in applied health research and evaluates their impact on clinical cost-sensitive outcomes and patient reported outcomes related to quality of life in noncommunicable diseases including cardiovascular disease, metabolic disease, chronic kidney disease and neurological disease (read more).

The project has been selected as the one from one of several funded by http://gender-net-plus.eu/joint-call/funded-projects/ under the consortium of 16 committed organisations from 13 countries aims to strengthen transnational collaborations between research programme owners and managers, provide support to the promotion of gender equality through institutional change http://gender-net-plus.eu/

This project is funded by